2 Summary Statistics

Data Notes:
  • Mpox was previously known as monkeypox
  • Primary, secondary & early non-primary non-secondary syphilis conditions are early-stage or recent infections.

    • 2.1 Top 20 Reportable Diseases

    Disease 2022 2021 2020 2019 2018
    Coronavirus, Novel (2019-nCoV) 145,864 141,296 116,904 <10 <10
    Chlamydia trachomatis infection 5,752 5,818 5,393 5,704 5,195
    Gonorrhea 1,986 2,327 1,959 1,877 1,864
    Influenza-associated hospitalization 932 49 481 786 843
    Tuberculosis, Latent Infection (LTBI) 669 482 365 564 482
    Hepatitis C virus infection, chronic 612 848 496 435 815
    Syphilis (primary, secondary, early latent) 290 213 138 168 183
    Campylobacteriosis 209 176 131 197 206
    Streptococcal disease, invasive, Group A 156 136 115 137 138
    Salmonellosis 143 119 110 140 115
    Mpox 140 0 0 0 0
    Hepatitis C, acute 118 131 54 75 89
    Streptococcus pneumoniae, invasive disease 110 92 75 118 116
    Streptococcal disease, invasive, Group B 108 105 103 116 100
    Pertussis 93 62 61 241 185
    Shiga toxin-producing Escherichia coli (STEC) 89 72 61 72 49
    HIV Infection, adult 87 63 71 81 77
    Giardiasis 83 85 63 99 103
    Cryptosporidiosis 73 35 40 67 53
    Enterobacter species - Carbapenem resistant 59 53 60 54 25

    2.2 Age <1 year: Top 10 Reportable Diseases

    Disease 2022 2021 2020 2019 2018
    Coronavirus, Novel (2019-nCoV) 2,132 1,030 421 0 0
    Respiratory Syncytial Virus (RSV) Activity 364 277 7 14 <5
    Influenza-associated hospitalization 35 <5 17 30 25
    Salmonellosis 8 7 <5 7 5
    Streptococcal disease, invasive, Group B 8 13 10 9 9
    Campylobacteriosis 5 <5 <5 <5 6
    Chickenpox (Varicella) <5 5 <5 <5 9
    Cryptosporidiosis <5 <5 <5 <5 <5
    Tuberculosis, Latent Infection (LTBI) <5 <5 <5 <5 <5
    Botulism, infant <5 <5 <5 <5 <5

    2.3 Age 1-4 years: Top 10 Reportable Diseases

    Disease 2022 2021 2020 2019 2018
    Coronavirus, Novel (2019-nCoV) 4,213 3,831 1,521 0 0
    Respiratory Syncytial Virus (RSV) Activity 389 310 <5 11 <5
    Influenza-associated hospitalization 61 <5 39 54 36
    Giardiasis 12 <5 <5 10 5
    Campylobacteriosis 9 9 10 12 11
    Tuberculosis, Latent Infection (LTBI) 9 <5 <5 <5 <5
    Salmonellosis 8 <5 7 7 12
    Shiga toxin-producing Escherichia coli (STEC) 8 9 <5 16 5
    Chickenpox (Varicella) 5 5 <5 13 14
    Cryptosporidiosis 5 <5 <5 <5 <5

    2.4 Age 5-17 years: Top 10 Reportable Diseases

    Disease 2022 2021 2020 2019 2018
    Coronavirus, Novel (2019-nCoV) 19,588 24,272 16,027 0 0
    Chlamydia trachomatis infection 392 405 425 453 443
    Influenza-associated hospitalization 97 5 31 60 49
    Respiratory Syncytial Virus (RSV) Activity 93 56 <5 <5 <5
    Gonorrhea 53 71 67 54 59
    Tuberculosis, Latent Infection (LTBI) 30 24 15 28 25
    Salmonellosis 21 13 12 12 6
    Campylobacteriosis 14 20 14 19 9
    Shiga toxin-producing Escherichia coli (STEC) 13 14 13 16 11
    Pertussis 12 <5 19 76 84

    2.5 Age 18-29 years: Top 10 Reportable Diseases

    Disease 2022 2021 2020 2019 2018
    Coronavirus, Novel (2019-nCoV) 34,608 35,019 31,823 0 0
    Chlamydia trachomatis infection 3,785 3,817 3,598 3,838 3,453
    Gonorrhea 991 1,062 1,005 946 944
    Tuberculosis, Latent Infection (LTBI) 139 91 75 136 130
    Syphilis (primary, secondary, early latent) 96 62 48 58 73
    Hepatitis C virus infection, chronic 89 138 78 68 138
    Influenza-associated hospitalization 82 10 30 37 49
    Mpox 45 0 0 0 0
    Campylobacteriosis 42 31 21 40 38
    Hepatitis C, acute 38 38 15 30 33

    2.6 Age 30-49 years: Top 10 Reportable Diseases

    Disease 2022 2021 2020 2019 2018
    Coronavirus, Novel (2019-nCoV) 48,301 48,649 40,074 0 0
    Chlamydia trachomatis infection 1,433 1,453 1,240 1,288 1,200
    Gonorrhea 819 1,005 777 756 739
    Hepatitis C virus infection, chronic 324 474 231 188 292
    Tuberculosis, Latent Infection (LTBI) 283 215 169 235 196
    Syphilis (primary, secondary, early latent) 156 121 64 81 89
    Influenza-associated hospitalization 133 10 85 117 89
    Mpox 85 0 0 0 0
    Syphilis, unknown duration or late 76 38 30 46 <5
    Campylobacteriosis 68 55 34 57 72

    2.7 Age 50-64 years: Top 10 Reportable Diseases

    Disease 2022 2021 2020 2019 2018
    Coronavirus, Novel (2019-nCoV) 22,001 18,958 18,311 0 0
    Influenza-associated hospitalization 178 10 122 170 174
    Hepatitis C virus infection, chronic 149 176 148 128 295
    Tuberculosis, Latent Infection (LTBI) 142 98 76 116 94
    Chlamydia trachomatis infection 133 133 126 112 92
    Gonorrhea 116 179 103 111 110
    Streptococcal disease, invasive, Group A 43 46 32 42 41
    Campylobacteriosis 41 31 25 37 39
    Streptococcal disease, invasive, Group B 39 40 37 40 27
    Syphilis (primary, secondary, early latent) 37 26 21 25 16

    2.8 Age 65+ years: Top 10 Reportable Diseases

    Disease 2022 2021 2020 2019 2018
    Coronavirus, Novel (2019-nCoV) 15,016 9,531 8,718 0 0
    Influenza-associated hospitalization 346 13 157 318 421
    Respiratory Syncytial Virus (RSV) Activity 90 74 <5 <5 <5
    Streptococcal disease, invasive, Group A 64 48 44 43 45
    Tuberculosis, Latent Infection (LTBI) 63 54 27 47 34
    Hepatitis C virus infection, chronic 49 56 36 49 86
    Enterobacter species - Carbapenem resistant 39 30 31 24 16
    Streptococcal disease, invasive, Group B 34 31 34 41 38
    Campylobacteriosis 30 26 26 28 30
    Streptococcus pneumoniae, invasive disease 29 23 20 27 29